GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » Cyclically Adjusted PB Ratio

Shanghai Haohai Biological Technology Co (HKSE:06826) Cyclically Adjusted PB Ratio : 1.50 (As of May. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio?

As of today (2024-05-31), Shanghai Haohai Biological Technology Co's current share price is HK$43.25. Shanghai Haohai Biological Technology Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was HK$28.92. Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio for today is 1.50.

The historical rank and industry rank for Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio or its related term are showing as below:

HKSE:06826' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 1.12   Med: 1.29   Max: 1.43
Current: 1.43

During the past 10 years, Shanghai Haohai Biological Technology Co's highest Cyclically Adjusted PB Ratio was 1.43. The lowest was 1.12. And the median was 1.29.

HKSE:06826's Cyclically Adjusted PB Ratio is ranked better than
55.66% of 654 companies
in the Biotechnology industry
Industry Median: 1.74 vs HKSE:06826: 1.43

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Shanghai Haohai Biological Technology Co's adjusted book value per share data of for the fiscal year that ended in Dec23 was HK$36.039. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is HK$28.92 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Chart

Shanghai Haohai Biological Technology Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 1.39

Shanghai Haohai Biological Technology Co Quarterly Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.39 -

Competitive Comparison of Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio falls into.



Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=43.25/28.92
=1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Haohai Biological Technology Co's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Shanghai Haohai Biological Technology Co's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=36.039/114.7809*114.7809
=36.039

Current CPI (Dec23) = 114.7809.

Shanghai Haohai Biological Technology Co Annual Data

Book Value per Share CPI Adj_Book
201412 4.653 99.000 5.395
201512 19.989 100.600 22.807
201612 20.344 102.600 22.759
201712 23.697 104.500 26.028
201812 25.633 106.500 27.626
201912 34.130 111.200 35.229
202012 36.599 111.500 37.676
202112 39.790 113.108 40.379
202212 35.366 115.116 35.263
202312 36.039 114.781 36.039

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Haohai Biological Technology Co  (HKSE:06826) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Shanghai Haohai Biological Technology Co Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Haohai Biological Technology Co (HKSE:06826) Business Description

Traded in Other Exchanges
Address
No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. It is also engaged in the research and development of biological engineering, pharmaceutical and ophthalmology products, and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.
Executives
Morgan Stanley 2201 Interest of corporation controlled by you
Dalton Investments Llc 2102 Investment manager
The Bank Of New York Mellon Corporation 2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc 2102 Investment manager
Kabouter Management Llc 2102 Investment manager
Royal Bank Of Canada 2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc 2102 Investment manager
Prudence Investment Management (hong Kong) Limited 2102 Investment manager

Shanghai Haohai Biological Technology Co (HKSE:06826) Headlines

No Headlines